IRIS - Res&Arch Institutional Research Information System - Research & Archive

BIANCHI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.487
EU - Europa 2.966
AS - Asia 2.537
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 272
AF - Africa 78
OC - Oceania 2
Totale 10.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.323
SG - Singapore 1.202
IT - Italia 666
UA - Ucraina 400
IE - Irlanda 394
CN - Cina 378
BR - Brasile 347
SE - Svezia 294
HK - Hong Kong 293
VN - Vietnam 288
RU - Federazione Russa 277
DE - Germania 223
FR - Francia 187
FI - Finlandia 140
RO - Romania 113
GB - Regno Unito 100
CA - Canada 82
IN - India 75
KR - Corea 58
AR - Argentina 46
BD - Bangladesh 40
TR - Turchia 34
CZ - Repubblica Ceca 33
CO - Colombia 28
BE - Belgio 25
PL - Polonia 25
IQ - Iraq 24
EC - Ecuador 19
CH - Svizzera 18
MX - Messico 17
PK - Pakistan 17
ZA - Sudafrica 17
NL - Olanda 16
CI - Costa d'Avorio 15
UZ - Uzbekistan 15
ES - Italia 13
ID - Indonesia 13
IL - Israele 13
JP - Giappone 13
CR - Costa Rica 12
PH - Filippine 12
VE - Venezuela 12
AT - Austria 11
GR - Grecia 11
CW - ???statistics.table.value.countryCode.CW??? 10
MA - Marocco 9
NI - Nicaragua 9
JM - Giamaica 8
LB - Libano 8
SA - Arabia Saudita 8
GT - Guatemala 7
PE - Perù 7
TN - Tunisia 7
LT - Lituania 6
PS - Palestinian Territory 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
JO - Giordania 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
EU - Europa 4
PR - Porto Rico 4
PY - Paraguay 4
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
LC - Santa Lucia 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
SC - Seychelles 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LR - Liberia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 10.541
Salva come PNG Salva come JPEG
Città #
Singapore 881
Chandler 427
Dublin 394
Perugia 327
Ashburn 320
San Jose 316
Hong Kong 289
San Mateo 232
Jacksonville 193
Santa Clara 161
Boardman 157
Dong Ket 135
Council Bluffs 114
Bucharest 111
Beijing 108
Wilmington 98
Medford 94
Princeton 94
Moscow 91
Altamura 89
Redmond 89
Munich 82
Lauterbourg 80
Ann Arbor 77
Andover 70
Des Moines 70
Lawrence 68
Los Angeles 64
Ho Chi Minh City 58
Seoul 57
New York 56
Falls Church 45
Dallas 38
São Paulo 38
The Dalles 35
Dearborn 34
Turku 32
Hanoi 31
Orem 30
Woodbridge 28
Chennai 26
Pisa 26
Saint Petersburg 26
Brussels 25
Milan 25
Chicago 24
Norwalk 22
Helsinki 21
Piscataway 21
North Bergen 20
Boston 18
Brno 18
Frankfurt am Main 18
Phoenix 18
Warsaw 18
Brooklyn 16
Fremont 16
Nuremberg 16
Abidjan 15
Atlanta 15
Denver 14
Montreal 14
San Paolo di Civitate 14
Toronto 14
Olomouc 13
Poplar 13
Rome 12
Tokyo 12
Izmir 11
London 11
Naples 11
San Francisco 11
Shanghai 11
Baghdad 10
Guangzhou 10
Haiphong 10
Johannesburg 10
Manchester 10
San Diego 10
San José 10
Willemstad 10
Belo Horizonte 9
Mumbai 9
Seattle 9
Buffalo 8
Columbus 8
Houston 8
Managua 8
Medellín 8
Bogotá 7
Fortaleza 7
Guayaquil 7
Miami 7
Nanjing 7
Paris 7
Philadelphia 7
Ankara 6
Buenos Aires 6
Charlotte 6
Den Haag 6
Totale 6.498
Salva come PNG Salva come JPEG
Nome #
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 220
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 220
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 215
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 212
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 201
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 198
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 190
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 180
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 179
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 169
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 167
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 160
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 159
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 157
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 152
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 150
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 149
The TGF-β/IDO axis in infectious tolerance. 145
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 145
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 143
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 142
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 138
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 138
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 134
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 134
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 131
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 130
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 129
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 128
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC]. 128
[Experimental models of immunochemotherapeutic synergism: study of the influence of the treatment schedule]. 128
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 127
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 123
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 123
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 121
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 119
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 118
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 117
Modulation of tryptophan catabolism by regulatory T cells 116
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 116
O6-alkylguanine-DNA alkyltransferase attenuates triazene-induced cytotoxicity and tumor cell immunogenicity in murine L1210 leukemia 114
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 113
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 113
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 111
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 110
T cell apoptosis by tryptophan catabolism 109
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 109
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 108
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 108
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 108
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 107
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 107
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 105
CTLA-4-Ig regulates tryptophan catabolism in vivo. 105
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 105
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 102
Dendritic cells, CD4+ lymphocytes and IL-12 in an experimental model of antitumor immunotherapy 101
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 99
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 98
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 98
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 97
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 97
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 97
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 95
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 95
Immunomodulatory properties of ribavirin in the mouse. 92
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 92
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 91
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 91
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 91
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 90
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 89
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 89
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 88
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 88
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 87
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 84
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 84
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 79
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 78
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 77
Induction of tumor suppression and delayed-type footpad reaction by transfer of lymphocytes sensitized to a xenogenized tumor variant. 75
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 73
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 72
Tryptophan catabolism in nonobese diabetic mice. 71
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 70
Molecular and genomic aspects of xenogenizing-alkylating drugs. 67
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentation of the CD8 alpha+ subset 62
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 61
Th1 and Th2 cell clones to poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo 59
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 56
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 55
The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy. 43
Totale 10.816
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022902 0 0 0 0 56 32 14 277 108 88 107 220
2022/20231.462 107 249 15 116 137 187 0 77 515 5 41 13
2023/2024559 35 85 15 9 3 9 150 17 50 12 63 111
2024/20251.340 23 113 98 72 160 62 47 88 231 85 208 153
2025/20263.171 189 240 161 421 365 315 535 229 327 275 78 36
2026/20271.041 66 99 203 585 88 0 0 0 0 0 0 0
Totale 10.816